AR240045A1 - Procedimiento para la obtencion de derivados de la piridazina activos sobre el sistema nervioso central. - Google Patents

Procedimiento para la obtencion de derivados de la piridazina activos sobre el sistema nervioso central.

Info

Publication number
AR240045A1
AR240045A1 AR295532A AR29553284A AR240045A1 AR 240045 A1 AR240045 A1 AR 240045A1 AR 295532 A AR295532 A AR 295532A AR 29553284 A AR29553284 A AR 29553284A AR 240045 A1 AR240045 A1 AR 240045A1
Authority
AR
Argentina
Prior art keywords
procedure
nervous system
central nervous
pyridazine derivatives
obtaining active
Prior art date
Application number
AR295532A
Other languages
English (en)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of AR240045A1 publication Critical patent/AR240045A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AR295532A 1983-01-27 1984-01-20 Procedimiento para la obtencion de derivados de la piridazina activos sobre el sistema nervioso central. AR240045A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
AR240045A1 true AR240045A1 (es) 1990-01-31

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
AR295532A AR240045A1 (es) 1983-01-27 1984-01-20 Procedimiento para la obtencion de derivados de la piridazina activos sobre el sistema nervioso central.

Country Status (27)

Country Link
US (1) US4721711A (es)
EP (1) EP0117779B1 (es)
JP (1) JPS59141564A (es)
KR (1) KR910000638B1 (es)
AR (1) AR240045A1 (es)
AT (1) ATE48417T1 (es)
AU (2) AU2372984A (es)
CA (1) CA1238637A (es)
DD (1) DD220026A5 (es)
DE (1) DE3480653D1 (es)
DK (1) DK162985C (es)
ES (1) ES8500243A1 (es)
FI (1) FI78691C (es)
FR (1) FR2540113A1 (es)
HU (1) HU193890B (es)
IE (1) IE57054B1 (es)
IL (1) IL70756A (es)
MA (1) MA20018A1 (es)
NO (1) NO840313L (es)
NZ (1) NZ206945A (es)
OA (1) OA07644A (es)
PH (1) PH21162A (es)
PL (1) PL142340B1 (es)
PT (1) PT77993B (es)
SG (1) SG93690G (es)
YU (1) YU14284A (es)
ZA (1) ZA84502B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP1430033A4 (en) * 2001-08-31 2004-12-15 Univ Northwestern PROTEIN KINASE ANTI-INFLAMMATORY AND INHIBITOR COMPOSITION AND METHOD OF USE
EP1812007B1 (en) * 2004-11-02 2011-09-07 Northwestern University Pyridazine compounds and methods
CN101087766B (zh) * 2004-11-02 2011-09-07 西北大学 哒嗪化合物、组合物和方法
EP2015750A2 (en) * 2006-04-28 2009-01-21 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
CA2650704A1 (en) * 2006-04-28 2007-11-08 Northwestern University Salts of pyridazine compounds
US20090325973A1 (en) * 2006-04-28 2009-12-31 Watterson D Martin Formulations containing pyridazine compounds
US8283351B2 (en) * 2007-04-02 2012-10-09 Institute For Oneworld Health Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
WO2009131951A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
WO2009131947A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising pyridazine derivatives
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
EP2341776A4 (en) * 2008-09-19 2012-05-30 Inst Oneworld Health COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING IMIDAZOL AND TRIAZOL DERIVATIVES
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions

Also Published As

Publication number Publication date
ES529081A0 (es) 1984-10-01
ZA84502B (en) 1984-09-26
EP0117779B1 (fr) 1989-12-06
AU2372984A (en) 1984-08-02
PH21162A (en) 1987-08-05
PT77993B (fr) 1986-04-10
NZ206945A (en) 1987-07-31
FR2540113B1 (es) 1985-05-17
FI78691B (fi) 1989-05-31
NO840313L (no) 1984-07-30
CA1238637A (en) 1988-06-28
FI840323A0 (fi) 1984-01-26
IE57054B1 (en) 1992-04-08
EP0117779A1 (fr) 1984-09-05
SG93690G (en) 1991-01-18
DD220026A5 (de) 1985-03-20
OA07644A (fr) 1985-05-23
MA20018A1 (fr) 1984-10-01
ATE48417T1 (de) 1989-12-15
ES8500243A1 (es) 1984-10-01
PL245931A1 (en) 1985-07-16
DK162985B (da) 1992-01-06
PL142340B1 (en) 1987-10-31
AU2142188A (en) 1989-03-16
DK162985C (da) 1992-06-01
JPS59141564A (ja) 1984-08-14
FI78691C (fi) 1989-09-11
KR910000638B1 (ko) 1991-01-31
DE3480653D1 (de) 1990-01-11
PT77993A (fr) 1984-02-01
IE840149L (en) 1984-07-27
FR2540113A1 (fr) 1984-08-03
KR840007586A (ko) 1984-12-08
DK38984D0 (da) 1984-01-27
IL70756A (en) 1987-03-31
AU652118B2 (en) 1994-08-18
FI840323A (fi) 1984-07-28
US4721711A (en) 1988-01-26
HU193890B (en) 1987-12-28
DK38984A (da) 1984-07-28
YU14284A (en) 1986-12-31
IL70756A0 (en) 1984-04-30

Similar Documents

Publication Publication Date Title
AR240045A1 (es) Procedimiento para la obtencion de derivados de la piridazina activos sobre el sistema nervioso central.
MX9203422A (es) Compuestos farmacologicamente activos para el sistema nervioso central.
ES2018781B3 (es) Sistema de cateter para angioplastia.
ES551924A0 (es) Procedimiento para la preracion de ester-2-(5-cloroquinolin-8-iloxi-5-acetico-alquilico.
MX9203552A (es) Sistema de suministro de capas multiples.
ES2013618B3 (es) Sistema de seguridad para vehiculos.
IT8023097A0 (it) Nuove tripeptidammidi agenti sul sistema nervoso centrale e procedimento per la loro preparazione.
ES2032299T3 (es) Procedimiento para obtener derivados de metil-penicilina 3-beta-sustituida.
ES553303A0 (es) Procedimiento mejorado para preparar polisocianuratos de poliisocianatos.
ES555546A0 (es) Procedimiento para preparar derivados de cinalina.
FI864845A0 (fi) Anordning foer utdelning av servetter.
IT8023096A0 (it) Tripeptidammidi agenti sul sistema nervoso centrale e procedimento per la loro preparazione.
ES549876A0 (es) Perfeccionamientos en los sistemas para la realizacion de perforaciones circulares en el suelo.
MX162508A (es) Mejoras en sistema de bloques entrelazados para la retencion de tierra en los rios,playas y similares
ES516843A0 (es) Procedimiento para la obtencion de derivados de fenol.
ES2017643B3 (es) Asiento para automoviles.
ES265306Y (es) Apoyo para la cabeza para asientos de vehiculos.
MX9200764A (es) Procedimiento para la preparacion de 3-hidroxipropanonitrilos 3-substituidos.
ES522171A0 (es) Sistema de cultivo intensivo perfeccionado.
ES2017632B3 (es) Sistema perfeccionado de construccion para edificios multipisos.
ES511501A0 (es) Procedimiento para la obtencion de derivados de la 1,7-dihidropirano (4,3-b) pirrol-4,6-diona con actividad analgesica.
MX9200765A (es) Procedimiento para la preparacion de 3-hidroxipropanonitrilos 3-substituidos.
IT7924441A0 (it) Derivati tienilmorfolinici attivi sul sistema nervoso centrale.
ES269671Y (es) Dispositivo de ensamblaje, perfeccionado para estructuras.
BR6701311U (pt) Sistema de aquecimento de acentos para w.c.